Virtual Library
Start Your Search
Wolf Lindwasser
Moderator of
-
+
12 - Debate #2 Neoadjuvant/Adjuvant CT+IO Is Most Likely to Cure the Most Patients (ID 12)
- Event: TTLC 2019
- Type: General Session
- Track:
- Presentations: 2
- Moderators:Wolf Lindwasser
- Coordinates: 2/22/2019, 09:05 - 09:20, Starlight Ballroom
-
+
Adjuvant Is Best (ID 12.02)
09:05 - 09:20 | Author(s): Martin Edelman
- Abstract
Abstract not provided
-
+
Neoadjuvant Is Best (ID 12.01)
09:05 - 09:20 | Author(s): Paul A. Bunn Jr.
- Abstract
Abstract not provided